Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

You Tang

Showing results (431-440 of 440) with videos related to

Pageof 44
Sort By:
You have reached the last page of results.This site can display upto 440 results.
Cancer Cell|August 30, 2016
GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma MetastasisQing-Hai Ye, Wen-Wei Zhu, Ju-Bo Zhang, et al.
International Journal of Biological Sciences|November 23, 2019
Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolizationValerie Fako, Sean P Martin, Yotsawat Pomyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2013
Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinomaWen-Wei Zhu, Jia-Jian Guo, Lei Guo, et al.
Journal of Cancer Research and Clinical Oncology|December 20, 2003
A decade's studies on metastasis of hepatocellular carcinomaZhao-You Tang, Sheng-Long Ye, Yin-Kun Liu, et al.
Journal of Hematology & Oncology|April 20, 2018
Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3aMan-Qing Cao, A-Bin You, Xiao-Dong Zhu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 3, 2004
[Effect of postoperative transcatheter arterial chemoembolization on hepatocellular carcinoma patients with residual tumor]Zheng-gang Ren, Zhi-ying Lin, Jing-lin Xia, et al.
Journal of Hematology & Oncology|January 25, 2018
miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3aMan-Qing Cao, A-Bin You, Xiao-Dong Zhu, et al.
Chinese Medical Journal|November 15, 2017
Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative ResectionHui-Chuan Sun, Lu Xie, Xin-Rong Yang, et al.
Chinese Clinical Oncology|April 6, 2015
Expert consensus on local ablation therapies for primary liver cancerMeng-Chao Wu, Zhao-You Tang, Sheng-Long Ye, et al.
Science (New York, N.Y.)|March 19, 2011
Cardiac myosin activation: a potential therapeutic approach for systolic heart failureFady I Malik, James J Hartman, Kathleen A Elias, et al.
Pageof 44

Showing results (431-440 of 440) with videos related to

Sort By:
Pageof 44
You have reached the last page of results.This site can display upto 440 results.
Cancer Cell|August 30, 2016
GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma MetastasisQing-Hai Ye, Wen-Wei Zhu, Ju-Bo Zhang, et al.
International Journal of Biological Sciences|November 23, 2019
Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolizationValerie Fako, Sean P Martin, Yotsawat Pomyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2013
Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinomaWen-Wei Zhu, Jia-Jian Guo, Lei Guo, et al.
Journal of Cancer Research and Clinical Oncology|December 20, 2003
A decade's studies on metastasis of hepatocellular carcinomaZhao-You Tang, Sheng-Long Ye, Yin-Kun Liu, et al.
Journal of Hematology & Oncology|April 20, 2018
Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3aMan-Qing Cao, A-Bin You, Xiao-Dong Zhu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 3, 2004
[Effect of postoperative transcatheter arterial chemoembolization on hepatocellular carcinoma patients with residual tumor]Zheng-gang Ren, Zhi-ying Lin, Jing-lin Xia, et al.
Journal of Hematology & Oncology|January 25, 2018
miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3aMan-Qing Cao, A-Bin You, Xiao-Dong Zhu, et al.
Chinese Medical Journal|November 15, 2017
Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative ResectionHui-Chuan Sun, Lu Xie, Xin-Rong Yang, et al.
Chinese Clinical Oncology|April 6, 2015
Expert consensus on local ablation therapies for primary liver cancerMeng-Chao Wu, Zhao-You Tang, Sheng-Long Ye, et al.
Science (New York, N.Y.)|March 19, 2011
Cardiac myosin activation: a potential therapeutic approach for systolic heart failureFady I Malik, James J Hartman, Kathleen A Elias, et al.
Pageof 44